Rahul Aras, PhD is currently President and CEO of Iterion Therapeutics Inc., a Houston based clinical stage biotechnology company.
He has more than 18 years of experience in the biotechnology sector, including all aspects of raising funding, product development, business development and executive management.
Prior to Iterion, he served as founding President and CEO of Juventas Therapeutics, where he successfully advanced their gene therapy platform from concept into mid-stage clinical trials and a partnership with a leading global pharmaceutical company. In addition, he has worked with several start-up biotechnology companies to accelerate growth through product proof of concept and value creation. He has held research positions at Vanderbilt University Medical Center and Massachusetts General Hospital, and he has published articles in several leading scientific journals.
Dr. Aras received a BS from Tufts University, and a PhD in biomedical research from New York University.